Dr. Paul Gavin
Chief Executive Officer
Since joining Phosphagenics in 2002, he has developed multiple opportunities for the Company such as transdermal drug delivery systems and drug enhancement platforms for chronic pain management.
Dr Gavin is an inventor of the TPM® platform technology for transdermal delivery, and has managed its evolution from discovery to clinical development, with a range of products.
Dr Gavin holds a BSc (Honours) and PhD in Biochemistry & Molecular Biology from Monash University, Melbourne. He is experienced in many aspects of R&D and has published a number of articles in peer reviewed journals.